CELU
Celularity Inc
NASDAQ: CELU · HEALTHCARE · BIOTECHNOLOGY
$0.93
-2.68% today
Updated 2026-04-30
Market cap
$32.01M
P/E ratio
—
P/S ratio
0.79x
EPS (TTM)
$-3.33
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Celularity Inc (CELU) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-64.9%
Last 4 quarters
Revenue YoY growth
-43.2%
Most recent quarter
EPS YoY growth
-20.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.4%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-4.4%
2025-11-14
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-14 | $-0.88 | +41.3% | $1.59 | $1.52 | -4.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-1.50 | $-0.88 | +41.3% | $5.28M | -43.2% |
| 2025-06-30 | $-0.75 | $-1.02 | -36.1% | $5.74M | -52.6% |
| 2025-03-31 | $-0.15 | $-0.60 | -300.0% | $18.13M | +23.5% |
| 2024-12-31 | — | $-0.59 | — | $18.13M | +378.9% |
| 2024-09-30 | $-1.40 | $-0.73 | +47.7% | $9.30M | +145.5% |
| 2024-06-30 | — | $-0.30 | — | $12.11M | +312.3% |
| 2024-03-31 | $-1.40 | $-1.03 | +26.7% | $14.68M | +273.1% |
| 2023-12-31 | $-0.03 | $-0.50 | -1566.7% | $3.79M | -8.3% |
| 2023-09-30 | $-0.03 | $-0.50 | -1561.7% | $3.79M | — |
| 2023-06-30 | $-0.03 | $-0.27 | -800.0% | $2.94M | — |
| 2023-03-31 | $-0.24 | $-0.41 | -70.8% | $3.94M | — |
| 2022-12-31 | $-0.25 | $-0.24 | +4.0% | $4.13M | — |
Frequently asked questions
Has Celularity Inc beaten earnings estimates?
Celularity Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -64.9% over the last 3 quarters.
How does CELU stock react to earnings?
CELU stock has moved an average of -4.4% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.
What is Celularity Inc's revenue growth rate?
Celularity Inc reported year-over-year revenue growth of -43.2% in its most recent quarter, with EPS growing -20.1% year-over-year.